TISSUECYTOMETRY BY TISSUEGNOSTICS
LIVE

Serial Number

79356287

Owner

TissueGnostics GmbH

Attorney

Ralph Locher

Filing Date

Oct 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TISSUECYTOMETRY BY TISSUEGNOSTICS Trademark

Serial Number: 79356287 • Registration: 7601821

TISSUECYTOMETRY BY TISSUEGNOSTICS is a trademark filed by TissueGnostics GmbH on October 4, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

TissueGnostics GmbH (5 trademarks)

Taborstraße 10/2/8

Entity Type: 27

Trademark Details

Filing Date

October 4, 2022

Registration Date

December 17, 2024

Published for Opposition

October 15, 2024

Goods & Services

Chemical products, namely, chemicals for industrial and scientific use; biological preparations for industrial and scientific use; diagnostic reagents for scientific use; diagnostics, namely, diagnostics staining kits comprised of diagnostic reagents for scientific use, and scanning computer hardware and downloadable analysis software for tissue cytometry, for scientific use; chemical diagnostic reagents for scientific use; indicators, namely, chemicals for scientific use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; in vitro diagnostic preparations, namely, antibody staining kits for scientific use comprised of diagnostic reagents and chemicals for scientific use; diagnostic reagents sold as a kit, the kit containing monoclonal antibodies and buffer solutions, other than for medical use; staining chemicals being fluorescence labelled monoclonal antibodies for scientific use; histological staining kits comprised of fluorescence labelled monoclonal antibodies and buffer solutions for scientific use; staining kits comprised of a combination of monoclonal antibodies relevant for specific diagnostic purposes, namely, for staining tissue sections for scientific use.

Medical and veterinary diagnostic preparations for analysis of tissue sections, not limited to but including cancer tissue; diagnostic reagents for medical use; diagnostic agents being fluorescence-labelled antibody staining kits comprised of diagnostic reagents and chemicals for medical use; diagnostic reagents for in vitro use in the field of medicine; in vitro diagnostic preparations in the nature of antibody staining kits comprised of diagnostic reagents for diagnostics, for medical use; staining preparations in the nature of fluorescence-labelled staining kits comprised of diagnostic reagents and chemicals for medical use; staining kits comprised of monoclonal antibodies and buffer solutions for medical use; quantitative staining kits comprised of specific monoclonal antibodies labelled with specific sets of fluorochromes for medical use.

Medical, surgical, therapeutic, dental and veterinary instruments and apparatus, namely, digital slide scanners; diagnostic apparatus and diagnostic measuring apparatus for medical use, namely, tissue image cytometers; analytical apparatus for histological use in the field of medicine, namely, tissue sample analyzers; analytical apparatus for medical purposes, namely, artificial intelligence-based decision support systems comprised of tissue image cytometers and sample analyzers for medical purposes, and downloadable computer software for analyzing tissue samples for detection of disease for histopathology.

Scientific, research, audiovisual, optical, weighing, measuring, signaling, detection, testing and inspecting apparatus and instruments, namely, microscope based digital slide scanners and tissue image cytometers; recorded and downloadable media, namely, microscopic images of tissue sections and cultures cells and organoids; downloadable and recorded computer software for management and analysis of microscopic images as well as image analysis and data visualization; computers and computer peripherals; downloadable and recorded software for evaluating medical samples for extracting information on tissue structures and cell populations relevant for understanding diseases and performing a diagnosis; downloadable and recorded software for evaluating scientific samples for visualization of cellular in-situ data; downloadable and recorded analysis software for analyzing tissue samples for the detection of specific disease status, not limited to but including cancer; downloadable and recorded analysis software for analyzing tissue samples stained with color reagents for immunohistochemistry and immunofluorescence; diagnostic apparatus for scientific use, namely, tissue image cytometers for analysis and diagnosis of human or veterinary tissue samples.

Scientific and technological services and research and design relating thereto, namely, scientific research and development services; industrial analysis and research services in the field of tissue research and histopathology; design and development of computer hardware and software; biological, clinical in the field of histology and medical research and analysis; histological medical research services; histological image analysis and tissue image cytometry development services; histological medical laboratory services; histological analysis, namely, cytometric analysis of tissue samples; consultancy services in the field of histology for scientific research and diagnostics; research and development of new products in the field of histology; research and development of microscopy-based diagnostic methods based on the analysis of tissue and cell cultures; analysis of human tissues for medical research; development of computer hardware and analytic software in the field of histology for scientific research and medical and clinical diagnostics.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 6, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 19, 2025 FICS
FINAL DISPOSITION PROCESSED
May 19, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 3, 2025 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 3, 2024 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 21, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 1, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 1, 2024 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 8, 2024 GNFN
FINAL REFUSAL E-MAILED
Mar 8, 2024 GNFR
FINAL REFUSAL WRITTEN
Mar 8, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 15, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 18, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 18, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 22, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jul 21, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 19, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 6, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 1, 2022 REPR